Tools & Techniques

“Right to Try” legislation may have compassion at its heart, but it does not do enough to ensure patient protection.

Looking at miRNA expression levels may improve our ability to subtype bladder cancers and provide the most appropriate and effective treatment

We Sit Down With Benjamin Garcia, University of Pennsylvania, USA.

Women, like men, want good medicines that have been tested in clinical trials involving fair representation of both sexes.

Talking at women in cannabis science, and meeting Raphael Mechoulam

Antibody drug conjugates have not yet lived up to their potential, but there is hope – if we turn to the right solutions and techniques.

How ATR-FTIR spectroscopy could lead to less invasive cancer prescreening

Preanalytical variability can be a hidden danger in skewing test results. What's the best way to detect and overcome it?

Artificial intelligence could have a huge impact on drug discovery.

Machine learning and DNA methylation could open up a new realm of diagnostic possibility